{
  "docId": "019de076-3901-734c-833f-b5b0e2d3aa41",
  "docSlug": "e86c5f257c7f518e1f9c16c922f96c7d",
  "documentTitle": "Exscientia | Investor Presentation Deck | 76 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 49,
  "pageCount": 76,
  "prevPage": 48,
  "nextPage": 50,
  "slideType": "solution",
  "function": "present_solution",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": "The slide uses a process flow diagram to explain the therapeutic mechanism and competitive advantage of the '539 molecule.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-3901-734c-833f-b5b0e2d3aa41/49",
  "deckHref": "/decks/019de076-3901-734c-833f-b5b0e2d3aa41",
  "deckJsonHref": "/decks/019de076-3901-734c-833f-b5b0e2d3aa41.json",
  "deckAnchorHref": "/decks/019de076-3901-734c-833f-b5b0e2d3aa41#slide-49",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 1,
        "x": 0,
        "y": 0.85
      },
      "kind": "callout",
      "text": "Patient selection strategies underway to identify patients most likely to respond",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "77144249-9a1d-47e8-b568-1ae5d97d0070",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.88,
        "x": 0.06,
        "y": 0.48
      },
      "kind": "diagram",
      "text": "NE to Quiescence -> LSD1i + Cytotoxic -> '539 Brain Penetrance",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4940c656-6332-4c96-955e-c64ced7d5850",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.88,
        "x": 0.06,
        "y": 0.2
      },
      "kind": "image",
      "text": "Mechanism of action illustration showing cell transition and brain targeting",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d84566ca-3c75-4427-8738-487724436205",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.28,
        "x": 0.66,
        "y": 0.6
      },
      "kind": "paragraph",
      "text": "Brain metastases develop in ~50% of SCLC patients. ‘539, a brain penetrant molecule, may target brain metastases as well as peripheral disease",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1e35e0c0-f817-48ee-a284-bfe0242b9a04",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.28,
        "x": 0.06,
        "y": 0.6
      },
      "kind": "paragraph",
      "text": "Inhibiting LSD1 upregulates NOTCH signalling which promotes differentiation of neuroendocrine cancer cells into quiescent cancer cells",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1edc5270-36ed-4162-be29-557e74554ac1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.28,
        "x": 0.36,
        "y": 0.6
      },
      "kind": "paragraph",
      "text": "Quiescent cells treated with an LSD1 inhibitor and cytotoxic agent combination undergo apoptosis",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "63260cb7-5062-4a65-893d-7ac85fbfbc75",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.7,
        "x": 0.07,
        "y": 0.13
      },
      "kind": "title",
      "text": "‘539 CNS penetrance may provide competitive differentiation",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5e377026-4e37-4381-9e87-7a9049533077",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.85,
        "x": 0.07,
        "y": 0.06
      },
      "kind": "title",
      "text": "LSD1 inhibition drives neuroendocrine SCLC to quiescence",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8618e77b-a2fa-4fb5-a2d2-b7fd206f6bd8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "d6e3ead6-cdf1-43fc-a1f9-f94ae410d303",
      "evidence": "Three-step horizontal arrow flow",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}